-
Published on Aug 19, 2016
Ray
Akers, founder of Akers Biosciences Inc (NASDAQ:AKER, AIM:AKR), said
the firm's BreathScan OxiChek device is a part of the group's digital
platform for health and well-being.
The firm has found the device to be “highly successful” in assessing a person's oxidative stress.
"The more oxidative stress you have then the less healthy you are and the faster you will age," explains Akers.
A user of the device can track their health and well being on a smart phone or tablet computer, he adds.
For now and the next couple of years, the device is on sale to professional users like, health practioners and fitness coaches but then the plan is to roll out a commercial version, said the firm's BreathScan OxiChek device is a part of the group's digital platform for health and well-being.
The firm has found the device to be “highly successful” in assessing a person's oxidative stress.
"The more oxidative stress you have then the less healthy you are and the faster you will age," explains Akers.
A user of the device can track their health and well being on a smart phone or tablet computer, he adds.
For now and the next couple of years, the device is on sale to professional users like, health practioners and fitness coaches but then the plan is to roll out a commercial version, said the firm's BreathScan OxiChek device is a part of the group's digital platform for health and well-being.
The firm has found the device to be “highly successful” in assessing a person's oxidative stress.
"The more oxidative stress you have then the less healthy you are and the faster you will age," explains Akers.
A user of the device can track their health and well being on a smart phone or tablet computer, he adds.
For now and the next couple of years, the device is on sale to professional users like, health practioners and fitness coaches but then the plan is to roll out a commercial version.
http://www.4-traders.com/AKERS-BIOSCIENCES-INC-15590054/
http://www.4-traders.com/AKERS-BIOSCIENCES-INC-15007693/
No comments:
Post a Comment